Simplify Logo

Full-Time

Director – Procurement and Strategic Sourcing

Confirmed live in the last 24 hours

Generate Biomedicines

Generate Biomedicines

51-200 employees

Generative biology drug discovery platform

AI & Machine Learning
Biotechnology

Expert

Cambridge, MA, USA

Category
Project Management
Strategy Development
Business & Strategy
Required Skills
Coupa
Requirements
  • Bachelor’s degree (BS in a science/technical field preferred) or higher
  • 12+ years of related Pharma/Biotech experience
  • Strategic sourcing and procurement experience
  • Extensive knowledge of R&D category management
  • Experience with Coupa is strongly preferred
Responsibilities
  • Lead and develop a team of procurement professionals
  • Establish Key Performance Indicators (KPIs) for Procurement Operations
  • Develop and oversee a procurement training program
  • Resolve purchasing related issues
  • Establish and execute R&D sourcing strategies
  • Develop and manage preferred and key supplier contracts
  • Build and maintain strong relationships with vendors
  • Identify and implement strategic sourcing improvement opportunities
  • Budget management and reporting
  • Knowledge of Sarbanes-Oxley requirements
Generate Biomedicines

Generate Biomedicines

View

Generate Biomedicines stands at the forefront of the therapeutics industry by pioneering the integration of machine learning, biological engineering, and medicine. This unique approach represents a fundamental shift in drug discovery, allowing for the precise crafting of novel medicines with specific therapeutic functions. The company's Generate Platform, which studies millions of proteins, not only catalyzes technical innovation but also promotes a culture of advanced research and development, making it an exciting environment for professionals passionate about cutting-edge biomedicine technology.

Company Stage

Series C

Total Funding

$693M

Headquarters

Somerville, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

-1%

1 year growth

2%

2 year growth

22%